Associate Director, Accounting Operations
Cogent Biosciences Inc - Waltham, Massachusetts, United States
Posted Oct 13, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Offered From the posting source checked Nov 16, 2026
- Verification
- Not verified checked Nov 20, 2026
- Salary
- $170K-$200K From the posting source checked Nov 16, 2026
- 401(k) match
- Reported from DOL Form 5500 industry filing (not employer-specific)
Was this benefit information wrong? Tell us.
Market context
- U.S. role benchmark (BLS OEWS)
- $106,409 U.S. median for this role
- Projected growth (BLS Employment Projections)
- +7.7% - Faster than average
74% above the BLS role benchmark for finance aggregate.
Matched to SOC 13-2011 - Finance aggregate by role bucket.
Source:U.S. Bureau of Labor Statistics, OEWS, May 2024andEmployment Projections, 2024-2034.
Role
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Company
- Equity
- Offered Verified - SEC 10-K source checked Nov 16, 2026
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Associate Director, Accounting Operations Waltham, Massachusetts, United States Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent's lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Bezuclastinib has exhibited promising initial data across all three trials: APEX in AdvSM, SUMMIT in NonAdvSM and PEAK in GIST, including an encouraging safety profile across 600+ patients in single agent and combination dosing. The Role: We are looking for a seasoned accounting leader to oversee day-to-day accounting operations, including accounts payable, vendor management, fixed assets, and procurement processes. This role provides strategic oversight of compliance, tax reporting, internal controls, and audit support while driving process improvements and automation initiatives. Responsibilities: - Own day-to-day accounting operations, including procurement, vendor management, accounts payable, fixed asset management, and supporting services and contracts - Prepare and review journal entries, accruals and account reconciliations based on assigned accounting areas and consistent with accounting operations - Provide leadership, direction, and oversight to the accounting operations team responsible for purchasing and PO maintenance, invoice processing, vendor maintenance, and payment execution - Generate and present critical metrics, such
Read the full description at job-boards.greenhouse.io. FewerJobs shows a preview and links to the original posting.
Apply link verified; last checked Nov 20, 2026.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
Manager, Cost Accounting
Cogent Biosciences Inc - Waltham, Massachusetts, United States
Associate Director, Accounting
Profound - Watertown, MA USA
Senior Director, Commercial Accounting
Immunome Inc - Bothell, Washington, United States
Director, Accounting
Revolution Medicines - Redwood City, California, United States